GlaxoSmithKline (GSK) Presents: BENLYSTA (belimumab)
Posted by
The National Black Nurse Practitioner Association
on
Houston, TX
This announcement has
2 attachments:
BENLYSTA (belimumab) is the first and only FDA -Approved Treatment for both Systemic Lupus Erythematosus (SLE) and Lupus Nephritis. Please see and share attached QR codes with patients and/or persons interested. Information is also available at benlysta.com
Specialties
Acute Care
Adult
Allergy/Immunology
Cardiovascular
Dermatology
Endocrinology
Family
Gastroenterology
Gerontological
Infectious Disease
Neonatal
Nephrology
Neurology
Oncology
Pain Management
Palliative
Pediatric
Psychiatric / Mental Health
Radiology
Rheumatology
Urology
Women's Health